Know Cancer

or
forgot password
  • cancer clinical trials in marquette, MI

  • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Melanoma (Skin)
    Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Prostate Cancer
    Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
    Marquette General Hospital
    Marquette, Michigan 49855
    Head and Neck Cancer
    Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome
    Marquette General Hospital
    Marquette, Michigan 49855
    Myelodysplastic Syndromes
    Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Head and Neck Cancer, Oral Complications
    Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Drug/Agent Toxicity by Tissue/Organ, Lung Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Prostate Cancer
    Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme
    Marquette General Hospital
    Marquette, Michigan 49855
    Brain and Central Nervous System Tumors
    Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
    Marquette General Hospital
    Marquette, Michigan 49855
    Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity
    Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Head and Neck Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Colorectal Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Metastatic Cancer, Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Marquette General Hospital
    Marquette, Michigan 49855
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Marquette General Hospital
    Marquette, Michigan 49855
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Marquette General Hospital

    Trial Locations
    Marquette General Hospital
    Upper Peninsula Hematology/Oncology Associates
    Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
    Marquette General Hospital
    Marquette, Michigan 49855
    Multiple Myeloma, Plasma Cell Neoplasm
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Lung Cancer
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Colorectal Cancer, Precancerous Condition
    Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Leukemia
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Marquette General Hospital
    Marquette, Michigan 49855
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Marquette General Hospital
    Marquette, Michigan 49855
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Lung Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    Marquette General Hospital
    Marquette, Michigan 49855
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Marquette General Hospital
    Marquette, Michigan 49855
    Metastatic Cancer
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Prostate Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Marquette General Hospital
    Marquette, Michigan 49855
    Brain and Central Nervous System Tumors
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Pancreatic Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Anal Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Marquette General Hospital
    Marquette, Michigan 49855
    Diarrhea, Radiation Enteritis
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Marquette General Hospital
    Marquette, Michigan 49855
    Breast Cancer
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Anemia, Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Head and Neck Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Marquette General Hospital
    Marquette, Michigan 49855
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Marquette General Hospital
    Marquette, Michigan 49855
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Marquette General Hospital
    Marquette, Michigan 49855
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Marquette General Hospital
    Marquette, Michigan 49855
    Sarcoma
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Marquette General Hospital
    Marquette, Michigan 49855
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Lung Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Marquette General Hospital
    Marquette, Michigan 49855
    Carcinoma of Unknown Primary
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Upper Michigan Cancer Center at Marquette General Hospital
    Marquette, Michigan 49855
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific